AL-001 Ophthalmic Injection

AL-001 · Beijing Anlong Biopharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AL-001 Ophthalmic Injection, covering 2024-12-05 to 2025-02-21. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of AL-001 Ophthalmic Injection in Subjects with WAMD [Phase 2]